Docarpamine (Martin Pharmaceuticals)

多卡巴胺 (Martin Pharmaceuticals)

Report date: 2024/11/27 10:30:35

Base Information

Drug NameDocarpamine (Martin Pharmaceuticals)
Drug Alias NameOral Docarpamine (Martin Pharmaceuticals)CIQUAAX
ClassificationSmall molecules
Mechanisms of ActionDopamine D1 receptor agonists
TargetsDopamine D1 receptor
Therapy Area/IndicationsMouth DiseasesLiver CirrhosisGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMartin Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMouth DiseasesLiver CirrhosisGastrointestinal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A